You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
眾生藥業(002317.SZ):腦栓通膠囊獲批國家中藥保護品種
格隆匯 01-22 21:17

格隆匯1月22日丨眾生藥業(002317.SZ)公佈,2025年1月21日,國家藥品監督管理局網站發佈了《中藥保護品種公吿(第22號)》(2025年第8號),國家藥品監督管理局批准廣東眾生藥業股份有限公司全資子公司廣東華南藥業集團有限公司的腦栓通膠囊為首家中藥二級保護品種。

腦栓通膠囊為國家醫保目錄獨家品種、公司核心產品,是中國工程院王永炎院士基於“毒損腦絡”病機學説研製的現代中成藥,可改善腦血循環、保護神經功能、減少卒中殘障,全病程守護卒中患者健康,是安全、經濟的缺血性腦卒中臨牀治療藥物。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account